Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/04/2012WO2012070890A3 Pharmaceutical composition comprising extract of lonicera japonica for prevention and treatment of gastroesophageal reflux disease
10/04/2012WO2012066537A3 Compositions for transdermal delivery of active agents
10/04/2012WO2012065022A3 Spiro-oxindole mdm2 antagonists
10/04/2012WO2012065019A3 Combination comprising pyridopyrimidinone inhibitors of pi3k alpha
10/04/2012WO2012064806A3 Methods and compositions for unsilencing imprinted genes
10/04/2012WO2012064557A3 Deodorizing compositions
10/04/2012WO2012056402A3 Formulations and methods for attenuating respiratory depression induced by opioid overdose
10/04/2012WO2012053011A3 Ophthalmic compositions comprising brinzolamide
10/04/2012WO2012036585A8 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same
10/04/2012WO2012024083A9 Oxathiazine and dithiine oxides as inhibitors of sulfhydryl-dependent biomolecules
10/04/2012WO2011117346A9 Endoparasiticidal compositions
10/04/2012WO2011090694A8 Orally administrable film dosage forms containing ondansetron
10/04/2012WO2011082375A3 Systems and methods for promoting wound healing
10/04/2012WO2011067608A8 Treatment of allodynia and hyperalgesia
10/04/2012WO2010039548A3 Chemical modifications of monomers and oligonucleotides with cycloaddition
10/04/2012WO2006122883A9 Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne
10/04/2012WO2006088547A3 Matching product system and method
10/04/2012US20120255045 Inducible small rna expression constructs for targeted gene silencing
10/04/2012US20120255043 Microrna as a cancer progression predictor and its use for treating cancer
10/04/2012US20120253312 Prevention of Infection
10/04/2012US20120253298 Layered tissue thickness compensator
10/04/2012US20120253258 Ocular system with anchoring implant and therapeutic agent
10/04/2012US20120253238 Compositions for solubilizing cells and/or tissue
10/04/2012US20120253219 Methods for Recommending Neurophysiological Disorder Therapy
10/04/2012US20120253191 Porphyrin nanovesicles
10/04/2012US20120253039 Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds
10/04/2012US20120252904 Mitf as a marker for predisposition to cancer
10/04/2012US20120252903 Cholesterol control agent
10/04/2012US20120252902 Treatment of adhd
10/04/2012US20120252901 Agomelatine and pharmaceutical compositions thereof
10/04/2012US20120252898 Method of producing a stabilized naturally occuring hydroxycitric acid (hca) from garcinia indica fruit
10/04/2012US20120252897 Combination composition comprising benzoyl peroxide and adapalene
10/04/2012US20120252896 Methods and compositions for modulation of t-cells via the kynurenine pathway
10/04/2012US20120252895 Therapeutic methods employing nitric oxide precursors
10/04/2012US20120252894 Compounds for alleviating pain and stress in fetus and newborn
10/04/2012US20120252892 Methods for treating fibromyalgia syndrome
10/04/2012US20120252891 Vanilloid Fatty Hydroxamates as Therapeutic Anti-inflammatory Pharmaceuticals
10/04/2012US20120252890 Process and compounds for the manufacture of oseltamivir and analogs thereof, and new antiviral agents
10/04/2012US20120252889 Polyketide molecules as anticancer agents
10/04/2012US20120252888 Compositions and Methods for Treating Neurologic Disorders
10/04/2012US20120252887 Composition and method for treating diabetes and metabolic disorders
10/04/2012US20120252886 Catechins for the treatment of amyloidosis
10/04/2012US20120252885 Dronabinol treatment for migraines
10/04/2012US20120252883 Method and Composition to Increase Radiation-Induced Tumor Therapeutic Effects
10/04/2012US20120252881 Therapeutic agent for tumor
10/04/2012US20120252880 Oligonucleotide Complex Compositions And Methods Of Use As Gene Alteration Tools
10/04/2012US20120252879 Modulation of huntingtin expression
10/04/2012US20120252878 Use of cathepsin h
10/04/2012US20120252876 Trans-acting rna switches
10/04/2012US20120252875 Methods and compositions for treating diseases, disorders or injury of the cns
10/04/2012US20120252874 Methods for delivery of sirna to the spinal cord and therapies arising therefrom
10/04/2012US20120252873 siRNA Targeting Interleukin-1 Receptor-associated Kinase 4 (IRAK4)
10/04/2012US20120252872 RNAi Modulation of APOB and Uses Thereof
10/04/2012US20120252871 Diagnosis and treatment of chronic lymphocytic leukemia (cll)
10/04/2012US20120252870 Indian Hedgehog (Ihh) as a Marker to Predict Osteoarthritis (OA) and Methods for the Prevention and Treatment of OA
10/04/2012US20120252869 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
10/04/2012US20120252868 Novel means and methods for the treatment of hearing loss and phantom hearing
10/04/2012US20120252867 Method of therapy and diagnosis of atherosclerosis
10/04/2012US20120252865 Carbamate derivatives in particular for the treatment of neurological disorders
10/04/2012US20120252864 Substituted isoindoline-1,3-dione derivatives
10/04/2012US20120252863 Triptans for the treatment of psoriasis
10/04/2012US20120252862 Dissolvable Film Strip Comprising Natural Components
10/04/2012US20120252861 Medical Compositions for Intravesical Treatment of Bladder Cancer
10/04/2012US20120252860 Novel N, N'-Hydrazino-bis-isatin Derivatives with Selective Activity Against Multidrug-Resistant Cancer Cells
10/04/2012US20120252859 Tricyclic Indeno-Pyrrole Derivatives as Serotonin Receptor Modulators
10/04/2012US20120252858 Compounds, compositions, and methods for the treatment of beta-amyloid diseases and synucleinopathies
10/04/2012US20120252857 Genotype specific methods for treating human subjects using 4-methylpyrazole
10/04/2012US20120252856 Pi3k/akt pathway subgroups in cancer: methods of using biomarkers for diagnosis and therapy
10/04/2012US20120252855 Methods For Treating Degenerative Diseases/Injuries
10/04/2012US20120252854 Crystalline forms of thiazolidinedione compound and its manufacturing method
10/04/2012US20120252853 Positive allosteric modulators of nicotinic acetylcholine receptor
10/04/2012US20120252852 Otamixaban formulations with improved stability
10/04/2012US20120252851 Delivery system for sustained release of a calcium-channel blocking agent
10/04/2012US20120252850 Niacin conjugated fatty acid mixtures and their uses
10/04/2012US20120252849 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
10/04/2012US20120252848 Liquid dosage forms of non-enterically coated acid-labile drugs
10/04/2012US20120252847 Novel form of s-omeprazole
10/04/2012US20120252846 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/04/2012US20120252845 Composition for sustained drug delivery comprising geopolymeric binder
10/04/2012US20120252844 2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds
10/04/2012US20120252843 Isoindoline compounds and methods of their use
10/04/2012US20120252842 Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
10/04/2012US20120252841 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators
10/04/2012US20120252840 Method of Treating Cancer
10/04/2012US20120252839 Gain-of-function bcl-2 inhibitors
10/04/2012US20120252838 Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
10/04/2012US20120252837 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/04/2012US20120252836 1,3-Dioxanes and Their Uses
10/04/2012US20120252835 Stable temsirolimus composition and process of preparing same
10/04/2012US20120252834 Novel use and method of rapamycin to treat toxic shock
10/04/2012US20120252833 Sustained-release product comprising a combination of a non-opioid amine and a non-steriodal anti-inflammatory drug
10/04/2012US20120252832 Abuse-resistant controlled-release opioid dosage form
10/04/2012US20120252831 Compositions of opioid antagonists and methods for treating scleroderma therewith
10/04/2012US20120252830 Substituted Aminobutyric Derivatives as Neprilysin Inhibitors
10/04/2012US20120252829 Tivozanib and capecitabine combination therapy
10/04/2012US20120252828 Pyridoquinazolinone m1 receptor positive allosteric modulators
10/04/2012US20120252827 Combination of therapy comprising zd6474 and a taxane
10/04/2012US20120252826 Combination Therapy
10/04/2012US20120252825 Beneficial effects of combination therapy on cholesterol
10/04/2012US20120252824 Drug Combinations and Uses in Treating a Coughing Condition
1 ... 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 ... 7860